These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 23714663

  • 1. [Small molecule inhibitor SB203580 enhances the antitumor effect of gefitinib in PC-9 and A549 lung cancer cell lines].
    Zhao YM, Su B, Yang XJ, Shi JY, Tang L, Zhang J, Li JY, Chen J.
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):103-8. PubMed ID: 23714663
    [Abstract] [Full Text] [Related]

  • 2. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 3. p38 inhibitor SB203580 sensitizes the resveratrol-induced apoptosis in human lung adenocarcinoma (A549) cells.
    Li H, Wang X, Chen T, Qu J.
    J Biochem Mol Toxicol; 2012 Jul 22; 26(7):251-7. PubMed ID: 22644961
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.
    Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Huang YC, Chen HJ, Syu JJ, Chen CY, Jian YT, Jian YJ, Lin YW.
    Lung Cancer; 2013 Dec 22; 82(3):397-406. PubMed ID: 24138903
    [Abstract] [Full Text] [Related]

  • 5. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
    Shen L, Li Z, Shen S, Niu X, Yu Y, Li Z, Liao M, Chen Z, Lu S.
    Lung Cancer; 2012 Dec 22; 78(3):193-200. PubMed ID: 22985911
    [Abstract] [Full Text] [Related]

  • 6. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.
    Tracy S, Mukohara T, Hansen M, Meyerson M, Johnson BE, Jänne PA.
    Cancer Res; 2004 Oct 15; 64(20):7241-4. PubMed ID: 15492241
    [Abstract] [Full Text] [Related]

  • 7. [Study of the relationship between early growth response gene 1 activity in p38 mitogen-activated protein kinase pathway and epirubicin resistance of human breast carcinoma cells].
    Xiao L, Hu JL, Cui W.
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun 15; 38(6):408-13. PubMed ID: 19781349
    [Abstract] [Full Text] [Related]

  • 8. Involvement of ROS in the inhibitory effect of thermotherapy combined with chemotherapy on A549 human lung adenocarcinoma cell growth through the Akt pathway.
    Wang L, Liu X, Wu Y, Wu W, Wu Y.
    Oncol Rep; 2012 Oct 15; 28(4):1369-75. PubMed ID: 22895800
    [Abstract] [Full Text] [Related]

  • 9. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways.
    Meng G, Wang W, Chai K, Yang S, Li F, Jiang K.
    Int J Oncol; 2015 Mar 15; 46(3):1007-17. PubMed ID: 25573072
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells.
    Tung CL, Jian YJ, Syu JJ, Wang TJ, Chang PY, Chen CY, Jian YT, Lin YW.
    Exp Cell Res; 2015 May 15; 334(1):126-35. PubMed ID: 25662161
    [Abstract] [Full Text] [Related]

  • 11. Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.
    Zhang SR, Xu YS, Jin E, Zhu LC, Xia B, Chen XF, Li FZ, Ma SL.
    Acta Pharmacol Sin; 2017 Jan 15; 38(1):100-109. PubMed ID: 27840409
    [Abstract] [Full Text] [Related]

  • 12. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
    Jeannot V, Busser B, Brambilla E, Wislez M, Robin B, Cadranel J, Coll JL, Hurbin A.
    Int J Cancer; 2014 Jun 01; 134(11):2560-71. PubMed ID: 24374738
    [Abstract] [Full Text] [Related]

  • 13. Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
    Wu M, Yuan Y, Pan YY, Zhang Y.
    Mol Med Rep; 2014 Aug 01; 10(2):931-8. PubMed ID: 24840891
    [Abstract] [Full Text] [Related]

  • 14. Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.
    Liang YC, Wu HG, Xue HJ, Liu Q, Shi LL, Liu T, Wu G.
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec 01; 33(6):845-851. PubMed ID: 24337846
    [Abstract] [Full Text] [Related]

  • 15. AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines.
    Puglisi M, Thavasu P, Stewart A, de Bono JS, O'Brien ME, Popat S, Bhosle J, Banerji U.
    Lung Cancer; 2014 Aug 01; 85(2):141-6. PubMed ID: 24957682
    [Abstract] [Full Text] [Related]

  • 16. [Mechanism of p38 mitogen-activated protein kinase inhibitor SB203580 to glucocorticoid sensitivity].
    Li W, Lin JT, Sun LC, Zhou TL, Zhang L, Shu J.
    Zhonghua Yi Xue Za Zhi; 2012 Sep 25; 92(36):2570-3. PubMed ID: 23158801
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells.
    Wu M, Yuan Y, Pan YY, Zhang Y.
    Mol Med Rep; 2014 Jun 25; 9(6):2417-22. PubMed ID: 24682085
    [Abstract] [Full Text] [Related]

  • 18. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
    Zhou J, Kwak KJ, Wu Z, Yang D, Li J, Chang M, Song Y, Zeng H, Lee LJ, Hu J, Bai C.
    Cell Physiol Biochem; 2018 Jun 25; 47(5):1909-1924. PubMed ID: 29961070
    [Abstract] [Full Text] [Related]

  • 19. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
    Han YC, Zeng XX, Wang R, Zhao Y, Li BL, Song M.
    Ai Zheng; 2007 Jan 25; 26(1):48-53. PubMed ID: 17222367
    [Abstract] [Full Text] [Related]

  • 20. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
    Qin B, Ariyama H, Baba E, Tanaka R, Kusaba H, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2006 Nov 25; 58(5):577-84. PubMed ID: 16532343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.